Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians

A Maury, A Lyoubi, N Peiffer-Smadja, T de Broucker, E Meppiel, A Maury, A Lyoubi, N Peiffer-Smadja, T de Broucker, E Meppiel

Abstract

Introduction: The past two decades have been marked by three epidemics linked to emerging coronaviruses. The COVID-19 pandemic highlighted the existence of neurological manifestations associated with SARS-CoV-2 infection and raised the question of the neuropathogenicity of coronaviruses. The aim of this review was to summarize the current data about neurological manifestations and diseases linked to human coronaviruses.

Material and methods: Articles have been identified by searches of PubMed and Google scholar up to September 25, 2020, using a combination of coronavirus and neurology search terms and adding relevant references in the articles.

Results: We found five cohorts providing prevalence data of neurological symptoms among a total of 2533 hospitalized COVID-19 patients, and articles focusing on COVID-19 patients with neurological manifestations including a total of 580 patients. Neurological symptoms involved up to 73% of COVID-19 hospitalized patients, and were mostly headache, myalgias and impaired consciousness. Central nervous system (CNS) manifestations reported in COVID-19 were mostly non-specific encephalopathies that represented between 13% and 40% of all neurological manifestations; post-infectious syndromes including acute demyelinating encephalomyelitis (ADEM, n=13), acute necrotizing encephalopathy (ANE, n=4), Bickerstaff's encephalitis (n=5), generalized myoclonus (n=3) and acute transverse myelitis (n=7); other encephalitis including limbic encephalitis (n=9) and miscellaneous encephalitis with variable radiologic findings (n=26); acute cerebrovascular diseases including ischemic strokes (between 1.3% and 4.7% of COVID-19 patients), hemorrhagic strokes (n=17), cerebral venous thrombosis (n=8) and posterior reversible encephalopathy (n=5). Peripheral nervous system (PNS) manifestations reported in COVID-19 were the following: Guillain-Barré syndrome (n=31) and variants including Miller Fisher syndrome (n=3), polyneuritis cranialis (n=2) and facial diplegia (n=2); isolated oculomotor neuropathy (n=6); critical illness myopathy (n=6). Neuropathological studies in COVID-19 patients demonstrated different patterns of CNS damage, mostly ischemic and hemorrhagic changes with few cases of inflammatory injuries. Only one case suggested SARS-CoV-2 infiltration in endothelial and neural cells. We found 10 case reports or case series describing 22 patients with neurological manifestations associated with other human coronaviruses. Among them we found four MERS patients with ADEM or Bickerstaff's encephalitis, two SARS patients with encephalitis who had a positive SARS-CoV PCR in cerebrospinal fluid, five patients with ischemic strokes associated with SARS, eight MERS patients with critical illness neuromyopathy and one MERS patient with Guillain-Barré Syndrome. An autopsy study on SARS-CoV patients demonstrated the presence of the virus in the brain of eight patients.

Conclusion: The wide range of neurological manifestations and diseases associated with SARS-CoV-2 is consistent with multiple pathogenic pathways including post-infectious mechanisms, septic-associated encephalopathies, coagulopathy or endothelitis. There was no definite evidence to support direct neuropathogenicity of SARS-CoV-2.

Keywords: COVID-19; Coronaviruses; Nervous System; Neurological manifestations; SARS-CoV-2.

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

References

    1. World Health Organization . 2020. WHO characterizes COVID-19 as a pandemic. [Published online March 11, 2020. Accessed March 14, 2020. ]
    1. Mao L., Jin H., Wang M. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi: 10.1001/jamaneurol.2020.1127.
    1. Romero-Sánchez C.M., Díaz-Maroto I., Fernández-Díaz E. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8) doi: 10.1212/WNL.0000000000009937. e1060-e1070 [Published online June 1, 2020:10.1212/WNL. 0000000000009937]
    1. Mahammedi A., Saba L., Vagal A. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: an Italian Multicenter Retrospective Observational Study. Radiology. 2020;297S(2) doi: 10.1148/radiol.2020201933. E270-E273.
    1. Guilmot A., Maldonado Slootjes S., Sellimi A. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2020:1–7. doi: 10.1007/s00415-020-10108-x.
    1. Agarwal P., Ray S., Madan A., Tyson B. Neurological manifestations in 404 COVID-19 patients in Washington State. J Neurol. 2020 doi: 10.1007/s00415-020-10087-z. [Published online August 6, 2020]
    1. Varatharaj A., Thomas N., Ellul M.A. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet Psychiatry. 2020;7(10):875–882. doi: 10.1016/S2215-0366(20)30287-X.
    1. Paterson R.W., Brown R.L., Benjamin L. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104–3120.
    1. Kremer S., Lersy F., Anheim M. Neurologic and neuroimaging findings in COVID-19 patients: A retrospective multicenter study. Neurology. 2020;95(13) doi: 10.1212/WNL.0000000000010112.
    1. Meppiel E., Peiffer-Smadja N., Maury A. Neurologic manifestations associated with COVID-19: a multicentre registry. Clin Microbiol Infect. 2020 doi: 10.1016/j.cmi.2020.11.005. S1198-743X(20)30698-4.
    1. Helms J., Kremer S., Merdji H. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268–2270.
    1. Brun G., Hak J.-F., Coze S. COVID-19 – White matter and globus pallidum lesions: demyelination or small-vessel vasculitis? Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e777. doi: 10.1212/NXI.0000000000000777.
    1. Hanafi R., Outteryck O. COVID-19 neurologic complication with CNS vasculitis-like pattern. AJNR Am J Neuroradiol. 2020;41(8):1384–1387.
    1. Novi G., Rossi T., Pedemonte E. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e797. doi: 10.1212/NXI.0000000000000797.
    1. Dixon L., Varley J., Gontsarova A. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e789. doi: 10.1212/NXI.0000000000000789.
    1. Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S., Griffith B. COVID-19 – associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020:201187. doi: 10.1148/radiol.2020201187. [Published online March 31, 2020]
    1. Efe I.E., Aydin O.U., Alabulut A., Celik O., Aydin K. COVID-19-associated encephalitis mimicking glial tumor. World Neurosurg. 2020;140:46–48. doi: 10.1016/j.wneu.2020.05.194.
    1. Moriguchi T., Harii N., Goto J. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–58. doi: 10.1016/j.ijid.2020.03.062.
    1. Wong P.F., Craik S., Newman P. Lessons of the month 1: a case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med (Lond) 2020 doi: 10.7861/clinmed.2020-0182. [Published online May 5, 2020]
    1. Bernard-Valnet R., Pizzarotti B., Anichini A. Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection. Eur J Neurol. 2020 doi: 10.1111/ene.14298. [Published online May 7 2020]
    1. Pilotto A., Odolini S., Masciocchi S. Steroid-responsive encephalitis in coronavirus disease 2019. Ann Neurol. 2020;88(2):423–427.
    1. Hayashi M., Sahashi Y., Baba Y., Okura H., Shimohata T. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion. J Neurol Sci. 2020;415:116941. doi: 10.1016/j.jns.2020.116941.
    1. Le Guennec L., Devianne J., Jalin L. Orbitofrontal involvement in a neuroCOVID-19 patient. Epilepsia. 2020 doi: 10.1111/epi.16612. [Published online June 26, 2020:epi.16612]
    1. Zanin L., Saraceno G., Panciani P.P. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. 2020 doi: 10.1007/s00701-020-04374-x. [Published online May 4, 2020]
    1. Rábano-Suárez P., Bermejo-Guerrero L., Méndez-Guerrero A. Generalized myoclonus in COVID-19. Neurology. 2020;95(6) e767-e772.
    1. Méndez-Guerrero A., Laespada-García M.I., Gómez-Grande A. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020 doi: 10.1212/WNL.0000000000010282. [Published online July 8, 2020:10.1212/WNL. 0000000000010282]
    1. Cohen M.E., Eichel R., Steiner-Birmanns B. A case of probable Parkinson's disease after SARS-CoV-2 infection. Lancet Neurol. 2020;19(10):804–805. doi: 10.1016/S1474-4422(20)30305-7.
    1. Pascual-Goñi E., Fortea J., Martínez-Domeño A. COVID-19-associated ophthalmoparesis and hypothalamic involvement. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e823. doi: 10.1212/NXI.0000000000000823.
    1. Pugin D., Vargas M.-I., Thieffry C. COVID-19-related encephalopathy responsive to high doses glucocorticoids. Neurology. 2020 doi: 10.1212/WNL.0000000000010354. [Published online July 17, 2020:101212/WNL.0000000000010354]
    1. Vellieux G., Rouvel-Tallec A., Jaquet P., Grinea A., Sonneville R., d’Ortho M.-P. COVID-19 associated encephalopathy: is there a specific EEG pattern? Clin Neurophysiol. 2020;131(8):1928–1930. doi: 10.1016/j.clinph.2020.06.005.
    1. Vespignani H., Colas D., Lavin B.S. Report of EEG finding on critically ill patients with COVID-19. Ann Neurol. 2020 doi: 10.1002/ana.25814. [Published online June 13, 2020:ana.25814]
    1. Perrin P., Collongues N., Baloglu S. Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur J Neurol. 2021;28(1):248–258. doi: 10.1111/ene.14491.
    1. Delorme C., Paccoud O., Kas A. Covid-19-related encephalopathy: a case series with brain FDG-PET/CT findings. Eur J Neurol. 2020;27(12):2651–2657. doi: 10.1111/ene.14478.
    1. von Weyhern C.H., Kaufmann I., Neff F., Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet. 2020 doi: 10.1016/S0140-6736(20)31282-4. [Published online June 2020:S0140673620312824]
    1. Solomon I.H., Normandin E., Bhattacharyya S. Neuropathological Features of COVID-19. N Engl J Med. 2020 doi: 10.1056/NEJMc2019373. [Published online June 12, 2020:NEJMc2019373]
    1. Reichard R.R., Kashani K.B., Boire N.A., Constantopoulos E., Guo Y., Lucchinetti C.F. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020 doi: 10.1007/s00401-020-02166-2. [Published online May 24, 2020]
    1. Jaunmuktane Z., Mahadeva U., Green A. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19. Acta Neuropathol. 2020;140(3):397–400. doi: 10.1007/s00401-020-02190-2.
    1. Kantonen J., Mahzabin S., Mäyränpää M.I. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. 2020;30(6):1012–1016. doi: 10.1111/bpa.12889.
    1. Deigendesch N., Sironi L., Kutza M. Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology. Acta Neuropathol. 2020;140(4):583–586. doi: 10.1007/s00401-020-02213-y.
    1. Paniz-Mondolfi A., Bryce C., Grimes Z. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J Med Virol. 2020;92(7):699–702. doi: 10.1002/jmv.25915.
    1. Moore J.B., June C.H. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474. doi: 10.1126/science.abb8925.
    1. Mazeraud A., Righy C., Bouchereau E., Benghanem S., Bozza F.A., Sharshar T. Septic-associated encephalopathy: a comprehensive review. Neurotherapeutics. 2020 doi: 10.1007/s13311-020-00862-1. [Published online May 6, 2020]
    1. Racchiusa S., Mormina E., Ax A., Musumeci O., Longo M., Granata F. Posterior reversible encephalopathy syndrome (PRES) and infection: a systematic review of the literature. Neurol Sci. 2019;40(5):915–922. doi: 10.1007/s10072-018-3651-4.
    1. Franceschi A.M., Ahmed O., Giliberto L., Castillo M. Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection. Am J Neuroradiol. 2020 doi: 10.3174/ajnr.A6595. [Published online May 21, 2020]
    1. Gaur P., Dixon L., Jones B., Lyall H., Jan W. COVID-19-associated cytotoxic lesions of the corpus callosum. Am J Neuroradiol. 2020 doi: 10.3174/ajnr.A6713. [Published online August 20, 2020]
    1. Lin J., Lawson E.C., Verma S., Peterson R.B., Sidhu R. Cytotoxic lesion of the corpus callosum in an adolescent with multisystem inflammatory syndrome and SARS-CoV-2 infection. Am J Neuroradiol. 2020 doi: 10.3174/ajnr.A6755. [Published online August 20, 2020]
    1. Abdel-Mannan O., Eyre M., Löbel U. Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.2687. [Published online July 1, 2020]
    1. Varga Z., Flammer A.J., Steiger P. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi: 10.1016/S0140-6736(20)30937-5.
    1. AlKetbi R., AlNuaimi D., AlMulla M., AlTalai N., Samir M., Kumar N. Acute myelitis as a neurological complication of COVID-19: a case report and MRI findings. Radiol Case Rep. 2020 doi: 10.1016/j.radcr.2020.06.001. [Published online June 6, 2020]
    1. Durrani M., Kucharski K., Smith Z., Fien S. Acute Transverse Myelitis Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Case Report. Clin Pract Cases Emerg Med. 2020;4(3):344–348. doi: 10.5811/cpcem.2020.6.48462.
    1. Munz M., Wessendorf S., Koretsis G. Acute transverse myelitis after COVID-19 pneumonia. J Neurol. 2020 doi: 10.1007/s00415-020-09934-w. [Published online May 26, 2020]
    1. Sarma D., Bilello L.A. A Case Report of Acute Transverse Myelitis Following Novel Coronavirus Infection. Clin Pract Cases Emerg Med. 2020;4(3):321–323. doi: 10.5811/cpcem.2020.5.47937.
    1. Sotoca J., Rodríguez-Álvarez Y. COVID-19-associated acute necrotizing myelitis. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e803. doi: 10.1212/NXI.0000000000000803.
    1. Valiuddin H., Skwirsk B., Paz-Arabo P. Acute transverse myelitis associated with SARS-CoV-2: a case-report. Brain Behav Immun Health. 2020;5:100091. doi: 10.1016/j.bbih.2020.100091.
    1. Aguiar de Sousa D., Sandset Else C., Elkind Mitchell S.V. The curious case of the missing strokes during the COVID-19 pandemic. Stroke. 2020;51(7):1921–1923. doi: 10.1161/STROKEAHA.120.030792.
    1. Merkler A.E., Parikh N.S., Mir S. Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs. Patients With Influenza. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.2730. [Published online July 2, 2020]
    1. Hernández-Fernández F., Valencia H.S., Barbella-Aponte R.A. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143(10):3089–3103. doi: 10.1093/brain/awaa239.
    1. Avula A., Nalleballe K., Narula N. COVID-19 presenting as stroke. Brain Behav Immun. 2020 doi: 10.1016/j.bbi.2020.04.077. [Published online April 28, 2020]
    1. Beyrouti R., Adams M.E., Benjamin L. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020 doi: 10.1136/jnnp-2020-323586. [Published online April 30, 2020:jnnp-2020-323586]
    1. Fara M.G., Stein L.K., Skliut M., Morgello S., Fifi J.T., Dhamoon M.S. Macrothrombosis and stroke in patients with mild Covid-19 infection. J Thromb Haemost. 2020;18(8):2031–2033. doi: 10.1111/jth.14938.
    1. Morassi M., Bagatto D., Cobelli M. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol. 2020 doi: 10.1007/s00415-020-09885-2. [Published online May 20, 2020]
    1. Oxley T.J., Mocco J., Majidi S. Large-vessel stroke as a presenting feature of COVID-19 in the young. N Engl J Med. 2020 doi: 10.1056/NEJMc2009787. [Published online April 28, 2020:e60]
    1. Zhang Y., Xiao M., Zhang S. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020;382(17):e38. doi: 10.1056/NEJMc2007575.
    1. Morassi M., Bigni B., Cobelli M., Giudice L., Bnà C., Vogrig A. Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? J Neurol. 2020 doi: 10.1007/s00415-020-09984-0. [Published online June 12, 2020]
    1. Mirzaee S.M.M., Gonçalves F.G., Mohammadifard M., Tavakoli S.M., Vossough A. Focal cerebral arteriopathy in a COVID-19 PEDIATRIC PATient. Radiology. 2020 doi: 10.1148/radiol.2020202197. [Published online June 2, 2020:202197]
    1. Ntaios George, Michel Patrik, Georgiopoulos Georgios Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke. Stroke. 2020;51(9):e254–e258. doi: 10.1161/STROKEAHA.120.031208.
    1. Yaghi S., Ishida K., Torres J. SARS2-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020 doi: 10.1161/STROKEAHA.120.030335. [Published online May 20, 2020:STROKEAHA120030335]
    1. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi: 10.1111/jth.14768.
    1. Zheng Y.-Y., Ma Y.-T., Zhang J.-Y., Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–260. doi: 10.1038/s41569-020-0360-5.
    1. García-García S., Cepeda S., Arrese I., Sarabia R., Letter: Hemorrhagic conditions affecting the central nervous system in COVID-19 patients. Neurosurgery. 2020 doi: 10.1093/neuros/nyaa253. [Published online June 3, 2020]
    1. Al-olama M., Rashid A., Garozzo D. COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report. Acta Neurochir. 2020 doi: 10.1007/s00701-020-04402-w. [Published online May 20, 2020]
    1. Kaya Y., Kara S., Akinci C., Kocaman A.S. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: a case report. J Neurol Sci. 2020 doi: 10.1016/j.jns.2020.116858. [Published online April 28, 2020]
    1. Kishfy L., Casasola M., Banankhah P. Posterior reversible encephalopathy syndrome in severe SARS-COV-2 infection. J Neurol Sci. 2020 doi: 10.1016/j.jns.2020.116943. [Published online May 23, 2020]
    1. Lu L., Xiong W., Liu D. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: a retrospective multicenter study. Epilepsia. 2020 doi: 10.1111/epi.16524. [Published online April 18, 2020]
    1. Louis S., Dhawan A., Newey C. Continuous electroencephalography characteristics and acute symptomatic seizures in COVID-19 patients. Clin Neurophysiol. 2020;131(11):2651–2656. doi: 10.1016/j.clinph.2020.08.003.
    1. Gigli G.L., Bax F., Marini A. Guillain–Barré syndrome in the COVID-19 era: just an occasional cluster? J Neurol. 2020 doi: 10.1007/s00415-020-09911-3. [Published online May 19, 2020]
    1. Alberti P., Beretta S., Piatti M. Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e741. doi: 10.1212/NXI.0000000000000741.
    1. Arnaud S., Budowski C., Ng Wing Tin S., Degos B. Post SARS-CoV-2 Guillain–Barré syndrome. Clin Neurophysiol. 2020;131(7):1652–1654. doi: 10.1016/j.clinph.2020.05.003.
    1. Bigaut K., Mallaret M., Baloglu S. Guillain-Barré syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e785. doi: 10.1212/NXI.0000000000000785.
    1. Camdessanche J.-P., Morel J., Pozzetto B., Paul S., Tholance Y., Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris) 2020 doi: 10.1016/j.neurol.2020.04.003. [Published online April 15, 2020]
    1. Coen M., Jeanson G., Culebras Almeida L.A. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection. Brain Behav Immun. 2020;87:111–112. doi: 10.1016/j.bbi.2020.04.074.
    1. Ottaviani D., Boso F., Tranquillini E. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020;41(6):1351–1354. doi: 10.1007/s10072-020-04449-8.
    1. Padroni M., Mastrangelo V., Asioli G.M. Guillain–Barré syndrome following COVID-19: new infection, old complication? J Neurol. 2020 doi: 10.1007/s00415-020-09849-6. [Published online April 24, 2020]
    1. Pfefferkorn T., Dabitz R., von Wernitz-Keibel T., Aufenanger J., Nowak-Machen M., Janssen H. Acute polyradiculoneuritis with locked-in syndrome in a patient with COVID-19. J Neurol. 2020 doi: 10.1007/s00415-020-09897-y. [Published online May 12, 2020]
    1. Scheidl E., Canseco D.D., Hadji-Naumov A., Bereznai B. Guillain-Barre syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. J Peripher Nerv Syst. 2020;25(2):204–207. doi: 10.1111/jns.12382.
    1. Sedaghat Z., Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020 doi: 10.1016/j.jocn.2020.04.062. [Published online April 15, 2020]
    1. Toscano G., Palmerini F., Ravaglia S. Guillain–Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020 doi: 10.1056/NEJMc2009191. [Published online April 17, 2020:NEJMc2009191]
    1. Virani A., Rabold E., Hanson T. Guillain–Barré Syndrome associated with SARS-CoV-2 infection. IDCases. 2020;20:e00771. doi: 10.1016/j.idcr.2020.e00771.
    1. Dinkin M., Gao V., Kahan J. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020 doi: 10.1212/WNL.0000000000009700. [Published online May 1, 2020]
    1. Gutiérrez-Ortiz C., Méndez A., Rodrigo-Rey S. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020 [Published online April 17, 2020]
    1. Juliao Caamaño D.S., Alonso Beato R. Facial diplegia, a possible atypical variant of Guillain–Barré Syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci. 2020 doi: 10.1016/j.jocn.2020.05.016. [Published online May 14, 2020]
    1. Wei H., Yin H., Huang M., Guo Z. The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study. J Neurol. 2020;267(5):1550–1553. doi: 10.1007/s00415-020-09773-9.
    1. Madia F., Merico B., Primiano G., Cutuli S.L., De Pascale G., Servidei S. Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit. Neurology. 2020 [Published online June 29, 2020:10.1212/WNL.0000000000010280]
    1. Giacomelli A., Pezzati L., Conti F. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa330. [Published online March 26, 2020]
    1. Lechien J.R., Chiesa-Estomba C.M., De Siati D.R. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 doi: 10.1007/s00405-020-05965-1. [Published online April 6, 2020]
    1. Bénézit F., Turnier P.L., Declerck C. Utility of hyposmia and hypogeusia for the diagnosis of COVID-19. Lancet Infect Dis. 2020;20(9):1014–1015. doi: 10.1016/S1473-3099(20)30297-8.
    1. Lau K.-K., Yu W.-C., Chu C.-M., Lau S.-T., Sheng B., Yuen K.-Y. Possible central nervous system infection by SARS coronavirus. Emerging Infect Dis. 2004;10(2):342–344. doi: 10.3201/eid1002.030638.
    1. Hung E.C.W., Chim S.S.C., Chan P.K.S. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003;49(12):2108–2109. doi: 10.1373/clinchem.2003.025437.
    1. Arabi Y.M., Harthi A., Hussein J. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) Infection. 2015;43(4):495–501. doi: 10.1007/s15010-015-0720-y.
    1. Kim J.-E., Heo J.-H., Kim H. Neurological complications during treatment of middle east respiratory syndrome. J Clin Neurol. 2017;13(3):227. doi: 10.3988/jcn.2017.13.3.227.
    1. Yeh E.A., Collins A., Cohen M.E., Duffner P.K., Faden H. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics. 2004;113(1 Pt 1):e73–e76. doi: 10.1542/peds.113.1.e73.
    1. Umapathi T., Kor A.C., Venketasubramanian N. Large artery ischaemic stroke in severe acute respiratory syndrome (SARS) J Neurol. 2004;251(10):1227–1231. doi: 10.1007/s00415-004-0519-8.
    1. Algahtani H., Subahi A., Shirah B. Neurological complications of Middle East respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep Neurol Med. 2016:2016. doi: 10.1155/2016/3502683.
    1. Al-Hameed F.M. Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus. Saudi Med J. 2017;38(2):196–200. doi: 10.15537/smj.2017.2.16255.
    1. Tsai L.-K., Hsieh S.-T., Chao C.-C. Neuromuscular disorders in severe acute respiratory syndrome. Arch Neurol. 2004;61(11):1669–1673. doi: 10.1001/archneur.61.11.1669.
    1. Gu J., Gong E., Zhang B. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202(3):415–424. doi: 10.1084/jem.20050828.
    1. Arbour N., Day R., Newcombe J., Talbot P.J. Neuroinvasion by human respiratory coronaviruses. J Virol. 2000;74(19):8913–8921. doi: 10.1128/JVI.74.19.8913-8921.2000.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner